Treatments For Prostate Cancer

Archive for November, 2011

In some men, the PSA may still rise after radiation therapy. Is this dangerous? Do all men need to be treated? Can those who are potentially in danger be identified and selectively treated. Learn the answers in the accompanying video.

Product Description
Over the last several decades epidemiological, human migratory studies, pre-clinical and even early phase clinical trials have suggested that dietary constituents may offer a protective effect in reducing the incidence of multiple cancers, including cancer of the prostate. Given the potential that some of these compounds have shown in pre-clinical and even some clinical investigations, it is essential to further identify and develop promising new agents in the hope of creating a broad spectrum of cancer chemopreventive agents. In our studies, we characterized two agents for prostate cancer chemoprevention: carnosol and alpha-mangostin. Carnosol, a dietary diterpene, found in Mediterranean herbs including basil, oregano, sage, and thyme has been shown to decrease prostate cancer cell viability. In our analysis we found carnosol to function as a dual disruptor of the androgen and estrogen receptor-alpha using in vitro and in vivo models. Further study found these traits to be unique when compared to FDA approved anti-androgens and anti-estrogens. alpha-Mangostin, a dietary xanthone, isolated from the mangosteen fruit, was also observed to decrease prostate cancer cell viability. We evaluated alpha-mangostin for kinase inhibition against 50 different kinases. Of those, alpha-mangostin was found to be most effective against CDK4. Our analysis describes the in vitro and in vivo inhibition of prostate cancer using alpha-mangostin. We are proposing that alpha-mangostin and carnosol have unique mechanisms of action and may be further developed as cancer chemopreventive agents.

Selected plant constituents for the prevention and treatment of prostate cancer.

• Thank you For visiting HealthGenesis!
• Visit our webstore for more wonderful products!

Product Description
Introduces a program for treating prostate cancer in a therapeutic approach that integrates conventional and alternative medical treatments and incorporates such supplements as plant sterols, lycopene, fish oil, and other cancer-fighting compounds.

The Prostate Miracle: New Natural Therapies That Can Save Your Life

BioPharma Institute’s Innovative Healthcare News with Christina Carmichael: This weeks topics: 1) An End to PSA Testing, and 2) Vitamin E and the Prostate 1. Does the US Preventive Services Task Force calling for an end to routine PSA testing for healthy men age 50 and older goes too far? Prostate cancer is the second most common cancer among men, after skin cancer. In 2010, nearly 220000 US men received a diagnosis of prostate cancer and an estimated 32050 died of the disease. 2. If your mother told you that vitamins are good than let us talk about vitamin E and the risk of prostate cancer? What did a major medical study find? High-dose vitamin E supplements increase the risk of prostate cancer, results of a large clinical trial show.

Product Description

Surviving Prostate Cancer: What You Need to Know to Make Informed Decisions

Product Description

Surviving Prostate Cancer: What You Need to Know to Make Informed Decisions

A prostate cancer survivor shares his experiences with his robotic prostatectomy at Henry Ford Hospital For more on Dr. Menon, visit www.henryford.com About the da Vinci Robotic Procedures The Vattikuti Urology Institute has performed more than 5000 robotic procedures. We have more experience performing robotic prostatectomy than any other surgical team in the world. Today, we are the only institution routinely offering a catheter-free approach to robotic prostatectomy. For more on Robotic Surgery, visit www.henryford.com About the Vattikuti Urology Institute Dr. Mani Menon and his surgical team offer unequaled quality and results. The Henry Ford Vattikuti Urology Institute, led by Mani Menon, MD, offers the most advanced treatments for prostate cancer, kidney disease, bladder cancer, and other urologic disease. Dr. Menon is known worldwide for developing robotic surgery for prostate cancer treatment. His robotic surgery innovations have made robotic prostatectomy the surgical standard of care for prostate cancer. Since performing the first robotic prostatectomy at Henry Ford Hospital in 2001, Dr. Menon and the Vattikuti Urology Institute team continue to have the longest and largest robotic prostate surgery experience in the US and the world: nearly 10 years and more than 5000 robotic prostate surgeries. For more information on the Vattikuti Urology Institute, visit www.henryford.com About Henry Ford Health System Henry Ford Health System (HFHS) is a Michigan not-for …

How to choose a primary treatment for prostate cancer. Men newly diagnosed with prostate cancer are generally told they have prostate cancer and given a long list of treatment options with little guidance. This video shares data gleaned from many men who have already faced a prostate cancer diagnosis and made a treatment choice. The lessons learned are shared with viewers.

A prostate cancer survivor shares his experiences with his robotic prostatectomy at Henry Ford Hospital For more on Dr. Menon, visit www.henryford.com About the da Vinci Robotic Procedures The Vattikuti Urology Institute has performed more than 5000 robotic procedures. We have more experience performing robotic prostatectomy than any other surgical team in the world. Today, we are the only institution routinely offering a catheter-free approach to robotic prostatectomy. For more on Robotic Surgery, visit www.henryford.com About the Vattikuti Urology Institute Dr. Mani Menon and his surgical team offer unequaled quality and results. The Henry Ford Vattikuti Urology Institute, led by Mani Menon, MD, offers the most advanced treatments for prostate cancer, kidney disease, bladder cancer, and other urologic disease. Dr. Menon is known worldwide for developing robotic surgery for prostate cancer treatment. His robotic surgery innovations have made robotic prostatectomy the surgical standard of care for prostate cancer. Since performing the first robotic prostatectomy at Henry Ford Hospital in 2001, Dr. Menon and the Vattikuti Urology Institute team continue to have the longest and largest robotic prostate surgery experience in the US and the world: nearly 10 years and more than 5000 robotic prostate surgeries. For more information on the Vattikuti Urology Institute, visit www.henryford.com About Henry Ford Health System Henry Ford Health System (HFHS) is a Michigan not-for …

Memorial Sloan-Kettering Cancer Center prostate cancer experts discuss a range of topics including new Veteran’s Administration guidelines on age and prostate cancer screening, the costs of radiation therapy vs. surgery, the effectiveness of proton beam therapy in prostate cancer, the difference between benign prostatic hyperplasia (BPH) and prostate cancer, chemopreventive drugs such as finasteride (Proscar) and dutasteride (Avodart), and the role of dietary supplements in prostate cancer care. For more information, please visit www.mskcc.org